
Sino Biological/SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb/1/40143-R019
商品编号:
40143-R019
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb General Information
Product name
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb
Validated applications
WB,ELISA
Application notes
IHC, FCM, IF, IP et al. applications haven"t been validated.(Antibody"s applications haven"t been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
Specificity
SARS Coronavirus NucleocapsidNo cross-reactivity in ELISA withMERS-CoV Nucleoprotein protein (40068-V08B)HCoV-229E Nucleoprotein protein (40640-V07E)HCoV-NL63 Nucleoprotein protein (40641-V07E)HCoV-HKU1(isolate N5) Nucleoprotein protein (40642-V07E)HCoV-OC43 Nucleoprotein (40643-V07E)
Preparation
This product is a recombinant monoclonal antibody expressed from HEK293 cells.
Source
Monoclonal Rabbit IgG Clone #019
Purification
Protein A
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb Validated Applications
Application | Dilution |
---|---|
WB | 1:1000-1:5000 |
ELISA | 1:5000-1:10000 |
Please Note: Optimal concentrations/dilutions should be determined by the end user.
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb Images

Anti-2019-nCoV NP rabbit monoclonal antibody at 1:1000 dilution.
Sample: 2019-nCoV NP Protein (Cat# 40588-V08B)
Lane A: 30ng
Lane B: 10ng
Lane C: 5ng
Lane D: 2ng
Lane E: 1ng
Lane F: 0.5ng
Secondary
Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution.
Developed using the ECL technique.
Performed under reducing conditions.
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit MAb: Synonyms
Anti-coronavirus NP Antibody; Anti-coronavirus Nucleocapsid Antibody; Anti-coronavirus Nucleoprotein Antibody; Anti-cov np Antibody; Anti-ncov NP Antibody; Anti-novel coronavirus NP Antibody; Anti-novel coronavirus Nucleocapsid Antibody; Anti-novel coronavirus Nucleoprotein Antibody; Anti-NP Antibody; Anti-Nucleocapsid Antibody; Anti-Nucleoprotein Antibody
Coronavirus Nucleocapsid Background Information
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. The coronavirus N protein is required for coronavirus RNA synthesis and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is the most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to the formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of the N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
References
- 1.Van Boheemen S, et al. (2012),MBio. 3(6):e00473-12.
- Bisht H. et al., 2004,Proc Natl Acad Sci. 101 (17): 6641-6.
- Li W. et al., 2005,Science.309 (5742): 1864-8.
- Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19)AuthorLarsen, CP;Bourne, TD;Wilson, JD;Saqqa, O;Sharshir, MA;Year2020JournalKidney Int RepApplicationIHCPubMed ID: 32292867FoldedExpand
- Proteomics of SARS-CoV-2-infected host cells reveals therapy targetsAuthorBojkova, D;Klann, K;Koch, B;Widera, M;Krause, D;Ciesek, S;Cinatl, J;Münch, C;Year2020JournalNatureApplicationViraM infection assayPubMed ID: 32408336FoldedExpand
- The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph NodesAuthorFeng, Z;Diao, B;Wang, R;Wang, G;Wang, C;Tan, Y;Year2020JournalmedRxivFoldedExpand
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2AuthorWang, H;Zhang, Y;Huang, B;Deng, W;Quan, Y;Wang, W;Xu, W;Zhao, Y;Li, N;Zhang, J;Liang, H;Bao, L;Xu, Y;Ding, L;Zhou, W;Gao, H;Liu, J;Niu, P;Zhao, L;Zhen, W;Fu, H;Yu, S;Zhang, Z;Xu, G;Li, C;Lou, Z;Xu, M;Qin, C;Wu, G;Gao, G;Tan, W;Yang, X;Year2020JournalCellApplicationWBFoldedExpand
- Sofosbuvir protects human brain organoids against SARS-CoV-2AuthorMesci, P;Macia, A;Saleh, A;Martin-Sancho, L;Yin, X;Snethlage, C;Avansini, S;Chanda, S;Muotri, A;Year2020JournalbioRxivApplicationIFFoldedExpand
- 上海 2 株严重急性呼吸综合征冠状病毒 2 的分离与鉴定Author彭浩然, ;李成忠, ;唐海琳, ;薛建亚, ;陈志辉, ;梁雪松, ;朱咏梅, ;夏炳辉, ;朱勇喆, ;吴俊杰, ;赵兰娟, ;任浩, ;江亮亮, ;何燕华, ;戚中田, ;赵平, ;Year2020Journal第二军医大学学报FoldedExpand
- SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patientsAuthorKlimstra, W;Tilston-Lunel, N;Nambulli, S;Boslett, J;McMillen, C;Gilliland, T;Dunn, M;Sun, C;Wheeler, S;Wells, A;Hartman, A;McElroy, A;Reed, D;Rennick, L;Duprex, W;Year2020JournalbioRxivApplicationImmunoplaque assayFoldedExpand
- Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2AuthorTakeda, Y;Murata, T;Jamsransuren, D;Suganuma, K;Kazami, Y;Batkhuu, J;Badral, D;Ogawa, H;Year2020JournalVirusesPubMed ID: 32605306FoldedExpand
- Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcomeAuthorpandolfi, l;Tommaso, F;Vanessa, F;Sara, B;Monica, M;Maura, D;Sara, L;Mario, U;Alessandro, D;Laura, S;Elena, P;Stefano, T;Lorenzo, C;Emanuela, C;Francesco, M;Paola, B;Davide, O;Daniele, L;Guido, C;Eloisa, A;Riccardo, C;Federica, M;Year2020JournalResearch SquareFoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们